Douglas A Levine Selected Research

Douglas A Levine Research Topics

Disease

89	Neoplasms (Cancer) 11/2021 - 11/2003
50	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 11/2005
26	Carcinoma (Carcinomatosis) 01/2022 - 11/2003
19	Ovarian Epithelial Carcinoma 01/2019 - 04/2005
14	Endometrial Neoplasms (Endometrial Cancer) 11/2022 - 05/2002
7	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2003
4	Carcinogenesis 02/2017 - 04/2010
4	Endometrioid Carcinoma 07/2015 - 12/2012
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013 - 04/2005
3	Small Cell Carcinoma 01/2019 - 01/2016
2	Uterine Neoplasms (Uterine Cancer) 11/2016 - 01/2016
2	Obesity 01/2016 - 02/2011
2	Ischemia 04/2015 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2011 - 12/2006
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2018
1	Uterine Diseases (Endometrial Disease) 01/2018
1	Hypertension (High Blood Pressure) 12/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2017
1	Chromosomal Instability (Chromosome Stability) 07/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Anastomotic Leak 01/2016

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2005
14	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2007
14	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 04/2005
11	PlatinumIBA 01/2019 - 08/2007
8	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2010
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 02/2008
4	Bevacizumab (Avastin)FDA Link 11/2022 - 12/2017
4	AntigensIBA 01/2020 - 07/2010
4	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 02/2017 - 02/2014
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2012
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 08/2013
3	Estrogen ReceptorsIBA 07/2015 - 09/2009
2	veliparibIBA 01/2022 - 06/2014
2	Formaldehyde (Formol)FDA Link 08/2021 - 05/2015
2	ParaffinIBA 08/2021 - 05/2015
2	temsirolimus FDA Link 01/2021 - 01/2018
2	ChromatinIBA 01/2019 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2019 - 10/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2014
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 02/2007
2	ProteomeIBA 07/2016 - 07/2014
2	Genetic Markers (Genetic Marker)IBA 03/2016 - 02/2011
2	Hormones (Hormone)IBA 01/2016 - 03/2015
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2016 - 05/2014
2	Hematoxylin (Haematoxylon)IBA 01/2016 - 04/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 04/2015
2	Coloring Agents (Dyes)IBA 01/2016 - 05/2009
2	Amino Acids FDA Link 01/2015 - 06/2014
2	Phosphotransferases (Kinase)IBA 07/2014 - 04/2005
2	taxaneIBA 01/2012 - 08/2007
2	Hyaluronic Acid (Hyaluronan)IBA 11/2010 - 11/2009
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 11/2010 - 11/2009
2	OligonucleotidesIBA 11/2005 - 12/2004
1	Matrix Metalloproteinases (MMPs)IBA 11/2022
1	ORALIT (ORS)IBA 01/2021
1	DNA Polymerase IIIBA 01/2021
1	Circular RNAIBA 01/2020
1	CateninsIBA 01/2020
1	Cyclin D1IBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Troleandomycin (TAO)FDA Link 01/2018
1	Circulating Tumor DNAIBA 01/2018
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	ixabepilone (BMS 247550)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2016
1	hydroxide ionIBA 10/2016
1	25-hydroxyvitamin DIBA 10/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2016
1	E platinumIBA 01/2016
1	Death Domain ReceptorsIBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 01/2022 - 11/2005
19	Therapeutics 01/2021 - 06/2008
7	Cytoreduction Surgical Procedures 01/2019 - 11/2009
4	Hysterectomy 11/2016 - 04/2005
4	Laparotomy 11/2010 - 05/2005
3	Immunotherapy 01/2021 - 01/2018
3	Salpingo-oophorectomy 11/2018 - 11/2013
3	Neoadjuvant Therapy 01/2017 - 01/2012
3	Lymph Node Excision (Lymph Node Dissection) 01/2016 - 04/2005
3	Lasers (Laser) 07/2013 - 04/2010
2	Radiotherapy 01/2021 - 05/2002
2	Length of Stay 01/2016 - 07/2009
2	Operative Surgical Procedures 10/2010 - 07/2003
2	Cholecystectomy 10/2010 - 09/2004
2	Splenectomy 10/2010 - 09/2004
2	Pancreatectomy 10/2010 - 09/2004
2	Prophylactic Mastectomy 09/2007 - 07/2003
2	Trachelectomy 12/2006 - 04/2005
1	Ileostomy 01/2016